SUPPLEMENT
Q3 2020 — Income statement trends
Q3 2020PDF · 2 pages225 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q118 Q218 Q318 Q418 Q119 Q219 Q319 Q419 Q120 Q220 Q320 Revenues: Clearing and transaction fees 973.6 906.1 752.5 1,034.8 952.6 1,051.8 1,040.7 901.0 1,278.8 940.2 835.4 Market data and information services 94.9 113.8 110.7 130.2 130.1 128.3 129.8 130.3 131.5 134.7 139.4 Other Revenue 40.5 39.7 41.0 71.6 96.9 92.6 106.8 107.1 111.8 107.4 105.9 Total revenues 1,109.0 1,059.6 904.2 1,236.6 1,179.6 1,272.7 1,277.3 1,138.4 1,522.1 1,182.3 1,080.7 Expenses: Compensation and benefits 152.7 150.8 144.9 223.8 230.3 227.3 223.5 217.6 207.5 217.0 216.4 Technology 25.5 25.2 24.7 41.8 47.1 48.6 52.7 53.1 47.7 49.1 48.1 Professional fees and outside services 42.6 31.9 31.3 60.3 39.4 41.7 43.2 49.8 41.7 51.2 48.4 Amortization of purchased intangibles 23.7 23.6 23.7 59.0 80.7 76.1 79.8 78.1 77.3 76.6 78.3 Depreciation and amortization 28.1 27.5 30.2 32.9 32.9 46.3 41.4 38.0 35.3 36.7 39.7 Licensing and other fee agreements 49.5 39.9 33.4 47.8 40.5 44.8 45.6 41.3 73.9 55.4 57.7 Other expense 46.0 93.8 66.1 121.1 77.7 89.3 105.9 87.5 78.8 58.8 67.1 Operating expenses 368.1 392.7 354.3 586.7 548.6 574.1 592.1 565.4 562.2 544.8 555.7 Operating Income 740.9 666.9 549.9 649.9 631.0 698.6 685.2 573.0 959.9 637.5 525.0 Operating Margin 67% 63% 61% 53% 53% 55% 54% 50% 63% 54% 49% Non-operating Income and Expense Investment income 156.4 241.9 161.5 185.3 178.7 139.3 172.3 147.6 95.9 32.1 23.6 Interest and other borrowing costs (30.1) (33.1) (45.0) (49.5) (48.1) (45.1) (42.8) (42.0) (40.9) (41.9) (41.7) Equity in net gains (losses) of unconsolidated subsidiaries 40.1 36.4 37.1 39.2 40.5 43.8 48.0 44.5 51.2 48.8 44.0 Other non-operating income (expense) (118.6) (155.3) (141.7) (154.4) (161.9) (134.5) (139.5) (99.0) (76.8) (15.2) (14.4) Non-operating income (expense) 47.8 89.9 11.9 20.6 9.2 3.5 38.0 51.1 29.4 23.8 11.5 Income before income taxes 788.7 756.8 561.8 670.5 640.2 702.1 723.2 624.1 989.3 661.3 536.5 Income taxes 189.9 190.7 150.0 283.5 144.3 187.5 86.9 155.1 222.5 158.0 125.0 Net income 598.8 566.1 411.8 387.0 495.9 514.6 636.3 469.0 766.8 503.3 411.5 Less: net income (loss) attributable to NCI - - - 1.5 (1.0) 0.8 - (0.5) 0.6 - (0.2) Net Income Attributable to CME Group 598.8 566.1 411.8 385.5 496.9 513.8 636.3 469.5 766.2 503.3 411.7 Effective Tax Rate 24.1% 25.2% 26.7% 42.3% 22.5% 26.7% 12.0% 24.9% 22.5% 23.9% 23.3% Earnings per Share: Basic EPS 1.76 1.67 1.21 1.10 1.39 1.44 1.78 1.31 2.14 1.41 1.15 Diluted EPS 1.76 1.66 1.21 1.09 1.39 1.43 1.78 1.31 2.14 1.40 1.15 Weighted average number of common stock shares: Basic Shares 339,305 339,465 339,586 350,921 356,886 357,060 357,211 357,456 357,524 357,691 357,791 Diluted Shares 340,747 340,872 341,035 352,132 358,047 358,155 358,369 358,354 358,455 358,457 358,590 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q118 Q218 Q318 Q418 Q119 Q219 Q319 Q419 Q120 Q220 Q320 Revenues: Clearing and transaction fees 973.6 906.1 752.5 1,034.8 952.6 1,051.8 1,040.7 901.0 1,278.8 940.2 835.4 Market data and information services 94.9 113.8 110.7 130.2 130.1 128.3 129.8 130.3 131.5 134.7 139.4 Other Revenue 40.5 39.7 41.0 71.6 96.9 92.6 106.8 107.1 111.8 107.4 105.9 Total revenues 1,109.0 1,059.6 904.2 1,236.6 1,179.6 1,272.7 1,277.3 1,138.4 1,522.1 1,182.3 1,080.7 Expenses: Compensation and benefits 151.0 148.5 142.2 199.9 219.7 218.7 219.2 207.1 210.9 202.7 205.5 Technology 25.5 25.2 24.7 41.8 47.1 48.1 52.5 51.5 47.3 48.5 47.3 Professional fees and outside services 24.4 25.8 24.9 32.6 33.7 36.0 37.1 41.4 35.3 42.7 40.0 Amortization of purchased intangibles - - - - - - - - - - - Depreciation and amortization 28.1 27.5 26.2 28.9 32.9 35.7 34.3 35.1 34.5 33.7 37.0 Licensing and other fee agreements 49.5 39.9 33.4 47.8 40.5 44.8 45.6 41.3 73.9 55.4 57.7 Other expense 44.4 45.6 43.4 81.4 69.4 67.5 66.4 83.8 57.6 51.9 56.1 Operating expenses 322.9 312.5 294.8 432.4 443.3 450.8 455.1 460.2 459.5 434.9 443.6 Operating Income 786.1 747.1 609.4 804.2 736.3 821.9 822.2 678.2 1,062.6 747.4 637.1 Operating Margin 71% 71% 67% 65% 62% 65% 64% 60% 70% 63% 59% Non-operating Income and Expense Investment income 155.0 151.3 161.0 179.4 176.7 161.0 165.4 126.1 102.3 26.4 22.6 Interest and other borrowing costs (29.9) (29.3) (30.1) (43.9) (48.1) (45.1) (42.8) (42.0) (42.6) (41.9) (41.7) Equity in net gains (losses) of unconsolidated subsidiaries 40.1 36.4 37.1 39.2 40.5 43.8 48.0 44.5 51.2 48.8 44.0 Other non-operating income (expense) (118.6) (118.4) (127.2) (143.5) (147.5) (132.2) (138.3) (99.2) (78.3) (15.2) (14.4) Non-operating income (expense) 46.6 40.0 40.8 31.2 21.6 27.5 32.3 29.4 32.6 18.1 10.5 Income before income taxes 832.7 787.1 650.2 835.4 757.9 849.4 854.5 707.6 1,095.2 765.5 647.6 Income taxes 199.2 195.7 155.2 209.4 179.7 217.0 175.3 163.7 258.8 182.3 152.8 Net income 633.5 591.4 495.0 626.0 578.2 632.4 679.2 543.9 836.4 583.2 494.8 Less: net income (loss) attributable to NCI - - - 1.5 (1.0) 0.8 - (0.5) 0.6 - (0.2) Net Income Attributable to CME Group 633.5 591.4 495.0 624.5 579.2 631.6 679.2 544.4 835.8 583.2 495.0 Effective Tax Rate 23.9% 24.9% 23.8% 25.1% 23.7% 25.6% 20.5% 23.1% 23.6% 23.8% 23.6% Earnings per Share: Basic EPS 1.87 1.74 1.46 1.78 1.62 1.77 1.90 1.52 2.34 1.63 1.38 Diluted EPS 1.86 1.74 1.45 1.77 1.62 1.76 1.90 1.52 2.33 1.63 1.38 Weighted average number of common stock shares: Basic Shares 339,305 339,465 339,586 350,921 356,886 357,060 357,211 357,456 357,524 357,691 357,791 Diluted Shares 340,747 340,872 341,035 352,132 358,047 358,155 358,369 358,354 358,455 358,457 358,590 -- 2 of 2 --